Product Information

AMLODIPINE-VALSARTAN 5-320 MG is a generic product labeled by Aurobindo Pharma Limited, priced at $0.3525 per EA under NDC 65862073830. Its NADAC has been published 511 times since Nov 9, 2016.

FDA first approved this application on Apr 22, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE-VALSARTAN 5-320 MG

Amlodipine and valsartan
$0.3525per EA

Strength

5; 320 mg/1; mg/1

NDC

65862073830

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA206512

FDA Approved

4/22/2016

TE Code

AB

On Market Since

4/22/2016

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for AMLODIPINE-VALSARTAN 5-320 MG has been published 511 times since Nov 9, 2016, and over the history we have for it it has declined 46.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3525 per EA
All-time high$0.6628 (Nov 16, 2016)
All-time low$0.3525 (Aug 19, 2026)
52-week high$0.5510
52-week low$0.3525
Median price$0.5612
Average price$0.5511
Largest weekly change+59.9% (Jun 19, 2024)
Weeks tracked511
Tracking sinceNov 9, 2016

Price History

1W

-6.6%

1M

-6.6%

3M

-30.7%

6M

-33.7%

1Y

-36.0%

3Y

-41.7%

5Y

-39.0%

All

-46.8%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Amlodipine and valsartan market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of AMLODIPINE-VALSARTAN 5-320 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-VALSARTAN 5-320 MG, manufactured by Aurobindo Pharma Limited, is $0.3525 per EA (NDC 65862073830), effective Aug 19, 2026.

How has the price of AMLODIPINE-VALSARTAN 5-320 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-VALSARTAN 5-320 MG has declined 46.8%. It has been tracked across 511 weekly CMS publications since Nov 9, 2016.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-VALSARTAN 5-320 MG?

Since Nov 9, 2016, the NADAC for AMLODIPINE-VALSARTAN 5-320 MG has ranged from a low of $0.3525 (Aug 19, 2026) to a high of $0.6628 (Nov 16, 2016), with a median of $0.5612 per EA.

Are there cheaper alternatives to AMLODIPINE-VALSARTAN 5-320 MG?

No other NADAC-published product currently shares the active ingredient and strength of AMLODIPINE-VALSARTAN 5-320 MG in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures AMLODIPINE-VALSARTAN 5-320 MG?

AMLODIPINE-VALSARTAN 5-320 MG (NDC 65862073830) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.